Free Trial
OTCMKTS:CUBT

Curative Biotechnology (CUBT) Stock Price, News & Analysis

Curative Biotechnology logo
$0.01 0.00 (-0.71%)
As of 02:19 PM Eastern

About Curative Biotechnology Stock (OTCMKTS:CUBT)

Key Stats

Today's Range
$0.0120
$0.0139
50-Day Range
$0.0095
$0.0155
52-Week Range
$0.00
$0.03
Volume
23,618 shs
Average Volume
164,587 shs
Market Capitalization
$13.47 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Curative Biotechnology, Inc., a development-stage biomedical company, focuses on novel treatments for rare diseases. The company focuses on therapies with potentially accelerated development paths as a result of the disease, the nature of the therapeutic itself, or the stage of clinical development. Its pipeline candidates include CURB906, an antibody-drug conjugate for targeting CD56 positive brain tumors; and IMT504, a novel immune therapy to treat rabies. The company has an agreement with Mid-Atlantic BioTherapeutics, Inc. to develop the COVID-19 vaccine. Curative Biotechnology, Inc. was founded in 1995 and is based in Boca Raton, Florida.

Receive CUBT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Curative Biotechnology and its competitors with MarketBeat's FREE daily newsletter.

CUBT Stock News Headlines

A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
SFRX Seafarer Exploration Corp.
See More Headlines

CUBT Stock Analysis - Frequently Asked Questions

Curative Biotechnology's stock was trading at $0.0128 at the beginning of 2025. Since then, CUBT shares have increased by 8.6% and is now trading at $0.0139.
View the best growth stocks for 2025 here
.

Shares of CUBT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Curative Biotechnology investors own include Ayala Pharmaceuticals (ADXS), Curative Biotechnology (CTYX), Invesco S&P Global Water Index ETF (CGW), Surge Battery Metals (NILIF), HEXO (HEXO), Pressure BioSciences (PBIO) and TransAtlantic Capital (TACI).

Company Calendar

Today
5/29/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Miscellaneous health & allied services, not elsewhere classified
Sub-Industry
N/A
Current Symbol
OTCMKTS:CUBT
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$13.47 million
Optionable
Not Optionable
Beta
0.28
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

This page (OTCMKTS:CUBT) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners